Breast, prostate, and thyroid cancer screening tests and overdiagnosis

Slides:



Advertisements
Similar presentations
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Advertisements

Overdiagnosis as an extreme form of length-time bias Breast cancer screening as example Juan Gérvas, MD, PhD, Equipo CESCA, Madrid, Spain
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
CT screening for lung cancer: Is the evidence strong enough? J.K. Field, A. Devaraj, S.W. Duffy, D.R. Baldwin Lung Cancer Volume 91, Pages (January.
ABO-incompatible kidney transplantation Kota Takahashi, Kazuhide Saito Transplantation Reviews Volume 27, Issue 1, Pages 1-8 (January 2013) DOI: /j.trre
Perimenopausal migraine in women with vasomotor symptoms E. Anne MacGregor Maturitas Volume 71, Issue 1, Pages (January 2012) DOI: /j.maturitas
Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.
Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Adaptation to Natural Binocular Disparities in Primate V1 Explained by a Generalized Energy Model Ralf M. Haefner, Bruce G. Cumming Neuron Volume 57, Issue.
Factors influencing delayed hospital presentation in patients with appendicitis: the APPE survey  Anne P. Ehlers, MD, MPH, F. Thurston Drake, MD, MPH,
Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit  Pim J. van Leeuwen, David Connolly, Anna.
The PSA Era is not Over for Prostate Cancer
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast.
Family Stress in Pediatric Critical Care
Volume 51, Issue 2, Pages (February 2007)
Stefano Caccavale, MD, Eleonora Ruocco, MD, PhD  Clinics in Dermatology 
The use of ondansetron for nausea and vomiting after head injury and its effect on return rates from the pediatric ED  Jesse J. Sturm, MD, MPH, Harold.
The benefits and harms of breast cancer screening
Validation and Application of the Arabic Version of the M. D
Prostate cancer diagnosis: should patients with prostate specific antigen >10ng/mL have stratified prostate biopsy protocols?  Joe Philip, MRCSI, Ramaswamy.
Triantafyllos Stylianopoulos, Lance L. Munn, Rakesh K. Jain 
Are patients willing to travel for better ovarian cancer care?
Volume 148, Issue 1, Pages (January 2018)
Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions  Anwar R. Padhani, Jeffrey Weinreb, Andrew.
The PSA Era is not Over for Prostate Cancer
Pain in cancer survivors; filling in the gaps
Limited Utility of Surveillance Imaging for Detecting Disease Relapse in Patients With Non-Hodgkin Lymphoma in First Complete Remission  Quoc Truong,
Volume 26, Issue 1, Pages 1-2 (July 2014)
Volume 63, Issue 3, Pages (March 2013)
What Palliative Care-Related Problems Do Patients Experience at HIV Diagnosis? A Systematic Review of the Evidence  Victoria M. Simms, MSc, Irene J. Higginson,
Malignancy-associated dermatomyositis: Retrospective case–control study from a single tertiary care center  Laura Kooistra, BS, Claudia Ricotti, BS, Fabrizio.
Body Composition, Physical Fitness, Functional Performance, Quality of Life, and Fatigue Benefits of Exercise for Prostate Cancer Patients: A Systematic.
William S. Asch, Margaret J. Bia  Advances in Chronic Kidney Disease 
Hepatitis C Virus Infection in the Older Patient
Surgical Management of Brain Metastases
It’s a SMAD/SMAD World Cell
Volume 53, Issue 1, Pages (January 2008)
Preclinical Rheumatic Disease
Psychological response and survival in breast cancer
Nancy E. Avis, PhD, Beverly Levine, PhD, Sarah A
PSA Levels and the Probability of Prostate Cancer on Biopsy
Volume 59, Issue 4, Pages (April 2011)
Challenges and Opportunities in Hormone-Resistant Prostate Cancer
Carol Chenoweth, MD, Sanjay Saint, MD, MPH  Critical Care Clinics 
Medical Care for Refugee Patients
Julie A. Wright Nunes, MD, MPH, Kerri L
Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia  Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,
Neuropsychological Assessment of Sport-Related Concussion
Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer  P. Mongiat-Artus, P. Teillac 
The Prevalence of Concern About Weight Loss and Change in Eating Habits in People with Advanced Cancer  Jane B. Hopkinson, PhD, RN, David N.M. Wright,
U.S. Hospice Benefits Journal of Pain and Symptom Management
Antibiotic De-Escalation
Study Designs in Patient-Oriented Research
Volume 17, Issue 2, Pages (February 1950)
Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer Center  J. Lynn Palmer, PhD, Michael J. Fisch, MD, MPH 
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Evaluating the Quality of Dying and Death
Intramedullary Spinal Tumors: Recent Advances and Future Directions
Treatment of Colorectal Cancer
The atypical pneumonias: clinical diagnosis and importance
Evaluation of diagnostic tests
Perceived Success in Addressing End-of-Life Care Needs of Low-Income Elders and Their Families: What Has Family Conflict Got to Do With It?  Betty J.
Victor T. Chang, MD, Charles B. Scott, PhD, Melanie L
Volume 51, Issue 2, Pages (February 2007)
Carcinoma of the esophagus: Prognostic significance of histologic type
The failure of breast cancer screening
Physical Function in Patients with Cancer
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Chapter 78 Vaccination and Screening in Cervical Cancer
Helping Patients with Advanced Cancer Live with Concerns About Eating: A Challenge for Palliative Care Professionals  Jane Hopkinson, PhD, RGN, Jessica.
Presentation transcript:

Breast, prostate, and thyroid cancer screening tests and overdiagnosis Minsoo Jung, PhD, MPH  Current Problems in Cancer  Volume 41, Issue 1, Pages 71-79 (January 2017) DOI: 10.1016/j.currproblcancer.2016.11.006 Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 1 Conceptual idea of lead-time bias. Note: The diagnosis of disease is made earlier in the screened group, resulting in an apparent increase in the survival time, although the survival time is the same in both groups. (Adapted with permission from Jung M.17) Current Problems in Cancer 2017 41, 71-79DOI: (10.1016/j.currproblcancer.2016.11.006) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 2 Conceptual idea of length-time bias. Note: The probability of detecting disease is related to the growth rate of the tumor. Rapidly growing tumors have short potential screening period. Thus, unless the screening test is repeated frequently, patients with aggressive tumors are more likely to present with symptoms. Tumors with slow growth have longer potential screening period. They are more likely to be detected when they are asymptomatic. As a result, more indolent tumors are found in the screened group, causing an apparent improvement in survival. (Adapted with permission from Jung M.17) Current Problems in Cancer 2017 41, 71-79DOI: (10.1016/j.currproblcancer.2016.11.006) Copyright © 2017 Elsevier Inc. Terms and Conditions